Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.22.2.2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Statement Of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 967,383 $ 922,654
Loans receivable, allowance for credit losses 71,584 72,557
Face amount of subordinated debentures 136,800 224,100
Unamortized discount and debt issuance costs $ 7,539 $ 9,094
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 33,705,973 33,603,839
Common stock outstanding (shares) 30,484,004 30,407,261
Accumulated other comprehensive (loss) income, tax benefit $ 41,170 $ 3,421
Treasury stock (shares) 3,221,969 3,196,578